19 May 2013
Keywords: bayer, aventis, blood, plasma, deal, signed, non-binding
Article | 25 February 2002
Bayer and Aventis have signed a non-binding letter of intent to set up ajoint venture for biological products, a move ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.